To include your compound in the COVID-19 Resource Center, submit it here.

GTx rises on stress urinary incontinence data

GTx Inc. (NASDAQ:GTXI) gained $6.44 (38%) to $23.25 on Monday after reporting data from 18 postmenopausal women with stress urinary incontinence in

Read the full 226 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE